The perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery

Mayo Clinic Proceedings

Volumn 88, Issue 7, 2013, Pages 674-682

  Barbara, David W ^a   Wetzel, David R ^a   Pulido, Juan N ^a   Pershing, Bryan S ^b   Park, Soon J ^a   Stulak, John M ^a   Zietlow, Scott P ^a   Morris, David S ^a   Boilson, Barry A ^a   Mauermann, William J ^a  

^a MAYO CLINIC   (United States)

^b FAIRVIEW SOUTHDALE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FRESH FROZEN PLASMA; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; CAUSE OF DEATH; CLINICAL ARTICLE; CONFERENCE PAPER; ELECTRONIC MEDICAL RECORD; ERYTHROCYTE; FEMALE; GENERAL ANESTHESIA; HOSPITAL DISCHARGE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MALE; MORTALITY; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84880199000     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.03.019     Document Type: Conference Paper

References (24)

1. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339(21):1522-1533.
2. Wilson SR, Givertz MM, Stewart GC, Mudge GH Jr. Ventricular assist devices: the challenges of outpatient management. J Am Coll Cardiol. 2009;54(18):1647-1659.
3. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50(8):741-747.
4. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-1443.
5. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54(4):312-321.
6. Goldstein DJ, Mullis SL, Delphin ES, et al. Noncardiac surgery in long-term implantable left ventricular assist-device recipients. Ann Surg. 1995;222(2):203-207.
7. McKellar SH, Morris DS, Mauermann WJ, Park SJ, Zietlow SP. Evolution of general surgical problems in patients with left ventricular assist devices. Surgery. 2012; 152(5):896-902.
8. Stone ME, Soong W, Krol M, Reich DL. The anesthetic considerations in patients with ventricular assist devices presenting for noncardiac surgery: a review of eight cases. Anesth Analg. 2002; 95(1):42-49.
9. Morgan JA, Paone G, Nemeh HW, et al. Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant. 2012;31(7):757-763.
10. Nicolosi AC, Pagel PS. Perioperative considerations in the patient with a left ventricular assist device. Anesthesiology. 2003; 98(2):565-570.
11. Oleyar M, Stone M, Neustein SM. Perioperative management of a patient with a nonpulsatile left ventricular-assist device presenting for noncardiac surgery. J Cardiothorac Vasc Anesth. 2010; 24(5):820-823.
12. Mauermann WJ, Rehfeldt KH, Park SJ. Transesophageal echocardiography in a patient in hemodynamic compromise after Jarvik 2000 implantation: the suckdown effect. Anesth Analg. 2008;107(3):791-792.
13. Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg. 2013;145(2):566-574.
14. Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141-156.
15. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29(1):1-10.
16. Wever-Pinzon O, Drakos SG, Kfoury AG, et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United Network for Organ Sharing thoracic organ allocation policy justified? Circulation. 2013;127(4):452-462.
17. Eckhauser AE, Melvin WV, Sharp KW. Management of general surgical problems in patients with left ventricular assist devices. Am Surg. 2006;72(2):158-161.
18. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28(9):881-887.
19. John R, Kamdar F, Liao K, et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg. 2008;136(5):1318-1323.
20. Ahmed M, Le H, Aranda JM Jr, Klodell CT. Elective noncardiac surgery in patients with left ventricular assist devices. J Cardiac Surg. 2012;27(5):639-642.
21. Rossi M, Serraino GF, Jiritano F, Renzulli A. What is the optimal anticoagulation in patients with a left ventricular assist device? Interact Cardiovasc Thorac Surg. 2012;15(4):733-740.
22. Garatti A, Bruschi G, Colombo T, et al. Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device. Am J Surg. 2009;197(6):710-714.
23. Votapka TV, Pennington DG, McBride LR, Kaminski DL, Andrus CH, Swartz MT. Noncardiac operations in patients supported with mechanical circulatory support devices. J Am Coll Surg. 1994;179(3):318-320.
24. Schmid C, Wilhelm M, Dietl KH, Schmidt C, Hammel D, Scheld HH. Noncardiac surgery in patients with left ventricular assist devices. Surgery. 2001;129(4):440-444.